26:@0.021502:0.039294:0.047607:0.039294:0.047607:0.019261:0.021502:0.019261:0.000000:0.000000
Drug-class overview:@0.097208:0.039084:0.342812:0.039084:0.342812:0.019649:0.097208:0.019649:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
MIMS ConCISe GuIde to CardIovaSCular, MetabolIC and endoCrIne dISeaSeS :@0.097141:0.974259:0.701335:0.974259:0.701335:0.960936:0.097141:0.960936:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.701335:0.974259:0.705081:0.974259:0.705081:0.960936:0.701335:0.960936:0.000000
VOLUME 1:@0.705252:0.974259:0.786566:0.974259:0.786566:0.959690:0.705252:0.959690:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
haemorrhaging    uncorrected hypovolaemia or :@0.096970:0.096840:0.479990:0.096840:0.479990:0.081852:0.096970:0.081852:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.224373:0.096324:0.233187:0.096324:0.233187:0.081640:0.224373:0.081640:0.000000
hypotension:@0.096989:0.112094:0.193663:0.112094:0.193663:0.097105:0.096989:0.097105:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effects:  :@0.096989:0.131805:0.210297:0.131808:0.210297:0.115417:0.096989:0.115414:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.200184:0.126024:0.206411:0.126024:0.206411:0.116468:0.200184:0.116468:0.000000
abdominal pain    apprehension    dizziness :@0.096979:0.147061:0.479999:0.147061:0.479999:0.132073:0.096979:0.132073:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.241374:0.146545:0.250187:0.146545:0.250187:0.131861:0.241374:0.131861:0.000000
:@0.384383:0.146545:0.393196:0.146545:0.393196:0.131861:0.384383:0.131861:0.000000
:@0.096998:0.161799:0.105811:0.161799:0.105811:0.147114:0.096998:0.147114:0.000000
 Facial flushing   Hypotension   Increased :@0.105811:0.162315:0.480018:0.162315:0.480018:0.147326:0.105811:0.147326:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.247608:0.161799:0.256421:0.161799:0.256421:0.147114:0.247608:0.147114:0.000000
:@0.380612:0.161799:0.389425:0.161799:0.389425:0.147114:0.380612:0.147114:0.000000
intra-ocular pressure in closed-angle glaucoma :@0.097017:0.177568:0.479999:0.177568:0.479999:0.162579:0.097017:0.162579:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.097017:0.192305:0.105830:0.192305:0.105830:0.177621:0.097017:0.177621:0.000000
 Methemoglobinemia :@0.105830:0.192821:0.291058:0.192821:0.291058:0.177832:0.105830:0.177832:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.304219:0.192305:0.313032:0.192305:0.313032:0.177621:0.304219:0.177621:0.000000
 Muscle twitching :@0.313032:0.192821:0.480037:0.192821:0.480037:0.177832:0.313032:0.177832:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.475823:0.192821:0.480037:0.192821:0.480037:0.177832:0.475823:0.177832:0.000000
:@0.097036:0.207558:0.105849:0.207558:0.105849:0.192874:0.097036:0.192874:0.000000
  nausea and vomiting   Palpitations   Para-:@0.105849:0.208074:0.475842:0.208074:0.475842:0.193086:0.105849:0.193086:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.301275:0.207558:0.310088:0.207558:0.310088:0.192874:0.301275:0.192874:0.000000
:@0.419039:0.207558:0.427852:0.207558:0.427852:0.192874:0.419039:0.192874:0.000000
doxical bradycardia   restlessness   retrosternal :@0.097036:0.223327:0.480037:0.223327:0.480037:0.208339:0.097036:0.208339:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.253496:0.222811:0.262309:0.222811:0.262309:0.208127:0.253496:0.208127:0.000000
:@0.368739:0.222811:0.377552:0.222811:0.377552:0.208127:0.368739:0.208127:0.000000
discomfort   Severe headache and throbbing :@0.097036:0.238581:0.480037:0.238581:0.480037:0.223592:0.097036:0.223592:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.190824:0.238065:0.199637:0.238065:0.199637:0.223380:0.190824:0.223380:0.000000
 :@0.475823:0.238581:0.480037:0.238581:0.480037:0.223592:0.475823:0.223592:0.000000
:@0.097036:0.253318:0.105849:0.253318:0.105849:0.238634:0.097036:0.238634:0.000000
 tachycardia:@0.105849:0.253834:0.198790:0.253834:0.198790:0.238845:0.105849:0.238845:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precaution:  :@0.097036:0.273545:0.271160:0.273551:0.271160:0.257160:0.097036:0.257154:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.261047:0.267767:0.267273:0.267767:0.267273:0.258211:0.261047:0.258211:0.000000
acute:@0.096978:0.288804:0.142005:0.288804:0.142005:0.273816:0.096978:0.273816:0.000000:0.000000:0.000000:0.000000:0.000000
coronary:@0.168406:0.288804:0.236697:0.288804:0.236697:0.273816:0.168406:0.273816:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
thrombosis:@0.263098:0.288804:0.350054:0.288804:0.350054:0.273816:0.263098:0.273816:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.376455:0.288288:0.385268:0.288288:0.385268:0.273604:0.376455:0.273604:0.000000
Cerebral:@0.411668:0.288804:0.475765:0.288804:0.475765:0.273816:0.411668:0.273816:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
haemorrhaging :@0.096978:0.304058:0.221380:0.304058:0.221380:0.289069:0.096978:0.289069:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.240064:0.303542:0.248877:0.303542:0.248877:0.288857:0.240064:0.288857:0.000000
 Closed-angle glaucoma. :@0.248877:0.304058:0.479979:0.304058:0.479979:0.289069:0.248877:0.289069:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Gradual withdrawal   Head trauma  Hypothermia :@0.096978:0.319311:0.479998:0.319311:0.479998:0.304322:0.096978:0.304322:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.249859:0.318795:0.258672:0.318795:0.258672:0.304110:0.249859:0.304110:0.000000
:@0.361696:0.318795:0.370509:0.318795:0.370509:0.304110:0.361696:0.304110:0.000000
:@0.096997:0.334048:0.105810:0.334048:0.105810:0.319364:0.096997:0.319364:0.000000
 Hypothyroidism :@0.105810:0.334564:0.253226:0.334564:0.253226:0.319575:0.105810:0.319575:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.268813:0.334048:0.277626:0.334048:0.277626:0.319364:0.268813:0.319364:0.000000
 Increased intracranial :@0.277606:0.334564:0.480017:0.334564:0.480017:0.319575:0.277606:0.319575:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
pressure    liver or renal disease   Malnutrition :@0.096997:0.349817:0.480017:0.349817:0.480017:0.334829:0.096997:0.334829:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.169695:0.349301:0.178508:0.349301:0.178508:0.334617:0.169695:0.334617:0.000000
:@0.364351:0.349301:0.373164:0.349301:0.373164:0.334617:0.364351:0.334617:0.000000
:@0.097016:0.364555:0.105829:0.364555:0.105829:0.349870:0.097016:0.349870:0.000000
 Marked anaemia   Monitor pulse and blood :@0.105829:0.365070:0.480036:0.365070:0.480036:0.350082:0.105829:0.350082:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.254881:0.364555:0.263694:0.364555:0.263694:0.349870:0.254881:0.349870:0.000000
pressure during infusion:@0.097036:0.380324:0.282898:0.380324:0.282898:0.365335:0.097036:0.365335:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Drug interactions:  :@0.097036:0.400035:0.262040:0.400041:0.262040:0.383650:0.097036:0.383644:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.251927:0.394256:0.258153:0.394256:0.258153:0.384700:0.251927:0.384700:0.000000
other drugs affecting the cardiovascular system  :@0.096979:0.415294:0.479979:0.415294:0.479979:0.400305:0.096979:0.400305:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096979:0.430031:0.105792:0.430031:0.105792:0.415347:0.096979:0.415347:0.000000
 Sildenafil potentiates hypotensive effects  :@0.105792:0.430547:0.479999:0.430547:0.479999:0.415558:0.105792:0.415558:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.096998:0.445284:0.105811:0.445284:0.105811:0.430600:0.096998:0.430600:0.000000
 other anti-anginal agents:@0.105811:0.445800:0.306259:0.445800:0.306259:0.430812:0.105811:0.430812:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
other anti-anginal agents:@0.096970:0.474165:0.381731:0.474165:0.381731:0.452611:0.096970:0.452611:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Ivabradine:@0.096970:0.501435:0.212629:0.501435:0.212629:0.479880:0.096970:0.479880:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Ivabradine lowers heart rate by selectively :@0.096970:0.515578:0.479951:0.515578:0.479951:0.500590:0.096970:0.500590:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
inhibiting If channels in the heart in a :@0.096970:0.530831:0.479951:0.530831:0.479951:0.515843:0.096970:0.515843:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
concentration-dependent:@0.096970:0.546085:0.297456:0.546085:0.297456:0.531096:0.096970:0.531096:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
manner:@0.326262:0.546085:0.386395:0.546085:0.386395:0.531096:0.326262:0.531096:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
without:@0.415200:0.546085:0.475776:0.546085:0.475776:0.531096:0.415200:0.531096:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
affecting any other cardiac ionic channels :@0.096970:0.561338:0.479970:0.561338:0.479970:0.546349:0.096970:0.546349:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
(including calcium or potassium). Ivabradine :@0.096970:0.576591:0.479970:0.576591:0.479970:0.561602:0.096970:0.561602:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
binds by entering and attaching to a site on :@0.096970:0.591844:0.479932:0.591844:0.479932:0.576856:0.096970:0.576856:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
the channel pore from the intracellular side :@0.096970:0.607098:0.479990:0.607098:0.479990:0.592109:0.096970:0.592109:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and disrupts If ion current flow, which prolongs :@0.096970:0.622351:0.479990:0.622351:0.479990:0.607362:0.096970:0.607362:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
diastolic depolarisation, lowering heart rate. the :@0.096970:0.637604:0.479970:0.637604:0.479970:0.622615:0.096970:0.622615:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
If currents are located in the sino-atrial node and :@0.096970:0.652857:0.480028:0.652857:0.480028:0.637869:0.096970:0.637869:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
are the home of all cardiac pacemaker activity. :@0.096970:0.668111:0.479932:0.668111:0.479932:0.653122:0.096970:0.653122:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Ivabradine therefore lowers the pacemaker :@0.096970:0.683364:0.479990:0.683364:0.479990:0.668375:0.096970:0.668375:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
firing rate, consequently lowering heart rate :@0.096970:0.698617:0.479970:0.698617:0.479970:0.683628:0.096970:0.683628:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
and reducing myocardial oxygen demand.  this :@0.096970:0.713870:0.479970:0.713870:0.479970:0.698882:0.096970:0.698882:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
allows for an improved oxygen supply and :@0.096970:0.729123:0.479951:0.729123:0.479951:0.714135:0.096970:0.714135:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
therefore mitigation of ischaemia, allowing for a :@0.096970:0.744377:0.479951:0.744377:0.479951:0.729388:0.096970:0.729388:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
higher exercise capacity and reduction in angina :@0.096970:0.759630:0.479932:0.759630:0.479932:0.744641:0.096970:0.744641:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
episodes.  :@0.096970:0.774883:0.188044:0.774889:0.188044:0.759901:0.096970:0.759894:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
4,5 :@0.168473:0.769105:0.183831:0.769105:0.183831:0.760367:0.168473:0.760367:0.000000:0.000000:0.000000:0.000000
Indications::@0.096970:0.794601:0.197358:0.794601:0.197358:0.778210:0.096970:0.778210:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.197355:0.788819:0.203582:0.788819:0.203582:0.779263:0.197355:0.779263:0.000000
Chronic stable angina pectoris in patients with :@0.096970:0.809857:0.479990:0.809857:0.479990:0.794869:0.096970:0.794869:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
normal sinus rhythm where β-blockers are :@0.096970:0.825110:0.479970:0.825110:0.479970:0.810122:0.096970:0.810122:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
contraindicated or not tolerated:@0.096970:0.840364:0.342811:0.840364:0.342811:0.825375:0.096970:0.825375:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Dosage::@0.096970:0.860075:0.166396:0.860075:0.166396:0.843684:0.096970:0.843684:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.166396:0.854294:0.172622:0.854294:0.172622:0.844738:0.166396:0.844738:0.000000
Initial dose: 5 mg twice daily, increased after :@0.096970:0.875332:0.479970:0.875332:0.479970:0.860344:0.096970:0.860344:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
2-4 weeks to 7.5 mg twice daily depending on :@0.096970:0.890585:0.480009:0.890585:0.480009:0.875597:0.096970:0.875597:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
therapeutic response.  titrate dose downwards :@0.096970:0.905839:0.479990:0.905839:0.479990:0.890850:0.096970:0.890850:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
if heart rate decreases below 50 bpm at rest or :@0.096970:0.921092:0.479951:0.921092:0.479951:0.906103:0.096970:0.906103:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
symptoms of bradycardia are experienced.:@0.096970:0.936636:0.422051:0.936636:0.422051:0.921647:0.096970:0.921647:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Indications:  :@0.524247:0.096558:0.634741:0.096562:0.634741:0.080172:0.524247:0.080167:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.624628:0.090778:0.630854:0.090778:0.630854:0.081222:0.624628:0.081222:0.000000
Chronic stable angina pectoris in patients with :@0.524251:0.112001:0.907271:0.112001:0.907271:0.097012:0.524251:0.097012:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
normal sinus rhythm as monotherapy or in :@0.524251:0.127439:0.907232:0.127439:0.907232:0.112451:0.524251:0.112451:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
combination with beta blockers (also indicated :@0.524251:0.142878:0.907252:0.142878:0.907252:0.127889:0.524251:0.127889:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
in patients already treated with beta blockers), to :@0.524251:0.158316:0.907290:0.158316:0.907290:0.143328:0.524251:0.143328:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
reduce Cv-events in adults in sinus rhythm with :@0.524251:0.173755:0.907252:0.173755:0.907252:0.158766:0.524251:0.158766:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
mild to moderate symptomatic HF and heart :@0.524251:0.189193:0.907252:0.189193:0.907252:0.174204:0.524251:0.174204:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
rate of ≥77 bpm  in combination with standard :@0.524251:0.204486:0.907290:0.204486:0.907290:0.189497:0.524251:0.189497:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
therapy, including beta blockers or when beta :@0.524251:0.219779:0.907232:0.219779:0.907232:0.204790:0.524251:0.204790:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
blockers contraindicated or not tolerated:@0.524251:0.235072:0.838364:0.235072:0.838364:0.220083:0.524251:0.220083:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Contraindications:  :@0.524251:0.254823:0.692141:0.254834:0.692141:0.238443:0.524251:0.238432:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.682028:0.249049:0.688254:0.249049:0.688254:0.239493:0.682028:0.239493:0.000000
not studied with abrupt conduction disorders :@0.524251:0.270127:0.907232:0.270127:0.907232:0.255138:0.524251:0.255138:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
(i.e. Wolff-Parkinson-White  syndrome   Cardiac :@0.524251:0.285420:0.907271:0.285420:0.907271:0.270431:0.524251:0.270431:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.827184:0.284904:0.835997:0.284904:0.835997:0.270219:0.827184:0.270219:0.000000
dysrhythmia    Sick sinus  syndrome    Sino-atrial :@0.524270:0.300712:0.907271:0.300712:0.907271:0.285724:0.524270:0.285724:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.626774:0.300197:0.635587:0.300197:0.635587:0.285512:0.626774:0.285512:0.000000
:@0.810212:0.300197:0.819025:0.300197:0.819025:0.285512:0.810212:0.285512:0.000000
block   Pacemaker    resting heart rate below :@0.524270:0.316005:0.907309:0.316005:0.907309:0.301017:0.524270:0.301017:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.574608:0.315489:0.583421:0.315489:0.583421:0.300805:0.574608:0.300805:0.000000
:@0.684367:0.315489:0.693180:0.315489:0.693180:0.300805:0.684367:0.300805:0.000000
60 bpm   Severe hypotension (lower than :@0.524289:0.331298:0.907290:0.331298:0.907290:0.316310:0.524289:0.316310:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.607743:0.330782:0.616556:0.330782:0.616556:0.316098:0.607743:0.316098:0.000000
90/50  mmHg   Severe liver dysfunction    new :@0.524289:0.346591:0.907271:0.346591:0.907271:0.331603:0.524289:0.331603:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.637954:0.346075:0.646767:0.346075:0.646767:0.331391:0.637954:0.331391:0.000000
:@0.851044:0.346075:0.859857:0.346075:0.859857:0.331391:0.851044:0.331391:0.000000
York Heart  association (nYHa) class III-Iv heart :@0.524289:0.361884:0.907271:0.361884:0.907271:0.346895:0.524289:0.346895:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
failure :@0.524289:0.377177:0.575397:0.377177:0.575397:0.362188:0.524289:0.362188:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.587885:0.376661:0.596698:0.376661:0.596698:0.361977:0.587885:0.361977:0.000000
  third-degree atrioventricular block :@0.596698:0.377177:0.907309:0.377177:0.907309:0.362188:0.596698:0.362188:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903095:0.377177:0.907309:0.377177:0.907309:0.362188:0.903095:0.362188:0.000000
:@0.524308:0.391954:0.533121:0.391954:0.533121:0.377270:0.524308:0.377270:0.000000
 Cardiogenic shock :@0.533121:0.392470:0.716347:0.392470:0.716347:0.377481:0.533121:0.377481:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.733146:0.391954:0.741959:0.391954:0.741959:0.377270:0.733146:0.377270:0.000000
 St John’s  Wort  :@0.741959:0.392470:0.907328:0.392470:0.907328:0.377481:0.741959:0.377481:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524328:0.407247:0.533141:0.407247:0.533141:0.392563:0.524328:0.392563:0.000000
 Concomitant strong cytochrome P450 inhibitors :@0.533141:0.407763:0.907309:0.407763:0.907309:0.392774:0.533141:0.392774:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524328:0.422540:0.533141:0.422540:0.533141:0.407855:0.524328:0.407855:0.000000
  unstable angina pectoris    acute coronary :@0.533141:0.423056:0.907328:0.423056:0.907328:0.408067:0.533141:0.408067:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.759220:0.422540:0.768033:0.422540:0.768033:0.407855:0.759220:0.407855:0.000000
syndrome   Pregnancy and lactation   Medicines :@0.524328:0.438349:0.907328:0.438349:0.907328:0.423360:0.524328:0.423360:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.606223:0.437833:0.615036:0.437833:0.615036:0.423148:0.606223:0.423148:0.000000
:@0.811251:0.437833:0.820064:0.437833:0.820064:0.423148:0.811251:0.423148:0.000000
prolonging  Qt  interval :@0.524328:0.453642:0.723005:0.453642:0.723005:0.438653:0.524328:0.438653:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.733666:0.453126:0.742479:0.453126:0.742479:0.438441:0.733666:0.438441:0.000000
  Immediately  after :@0.742479:0.453642:0.907328:0.453642:0.907328:0.438653:0.742479:0.438653:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
stroke   Second-degree atrioventricular block :@0.524347:0.468935:0.907367:0.468935:0.907367:0.453946:0.524347:0.453946:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.582747:0.468419:0.591560:0.468419:0.591560:0.453734:0.582747:0.453734:0.000000
 :@0.903153:0.468935:0.907367:0.468935:0.907367:0.453946:0.903153:0.453946:0.000000
:@0.524366:0.483712:0.533179:0.483712:0.533179:0.469027:0.524366:0.469027:0.000000
 Galactose intolerance   lapp lactase deficiency :@0.533179:0.484227:0.907367:0.484227:0.907367:0.469239:0.533179:0.469239:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.709439:0.483712:0.718252:0.483712:0.718252:0.469027:0.709439:0.469027:0.000000
or glucose-galactose malabsorption   efficacy and :@0.524366:0.499520:0.907348:0.499520:0.907348:0.484532:0.524366:0.484532:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.800879:0.499004:0.809692:0.499004:0.809692:0.484320:0.800879:0.484320:0.000000
safety not established in children or adolescents:@0.524347:0.514813:0.892165:0.514813:0.892165:0.499825:0.524347:0.499825:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Side effects:  :@0.524347:0.534564:0.637570:0.534566:0.637570:0.518175:0.524347:0.518173:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.627457:0.528781:0.633683:0.528781:0.633683:0.519225:0.627457:0.519225:0.000000
transient visual symptoms (mainly phosphenes) :@0.524251:0.549859:0.907233:0.549859:0.907233:0.534870:0.524251:0.534870:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
of mild to moderate intensity   Sinus bradycardia :@0.524251:0.565152:0.907271:0.565152:0.907271:0.550163:0.524251:0.550163:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.754371:0.564636:0.763184:0.564636:0.763184:0.549951:0.754371:0.549951:0.000000
:@0.524270:0.579929:0.533083:0.579929:0.533083:0.565244:0.524270:0.565244:0.000000
  blurred vision    bradycardia    atrioventricular :@0.533083:0.580444:0.907291:0.580444:0.907291:0.565456:0.533083:0.565456:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.655388:0.579929:0.664201:0.579929:0.664201:0.565244:0.655388:0.565244:0.000000
:@0.768303:0.579929:0.777116:0.579929:0.777116:0.565244:0.768303:0.565244:0.000000
first-degree  block :@0.524290:0.595737:0.673726:0.595737:0.673726:0.580749:0.524290:0.580749:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.684771:0.595221:0.693584:0.595221:0.693584:0.580537:0.684771:0.580537:0.000000
  ventricular  extrasystoles :@0.693584:0.595737:0.907291:0.595737:0.907291:0.580749:0.693584:0.580749:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903076:0.595737:0.907291:0.595737:0.907291:0.580749:0.903076:0.580749:0.000000
:@0.524290:0.610514:0.533103:0.610514:0.533103:0.595830:0.524290:0.595830:0.000000
 Palpitations   Supraventricular extrasystoles :@0.533103:0.611030:0.907310:0.611030:0.907310:0.596042:0.533103:0.596042:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.646652:0.610514:0.655465:0.610514:0.655465:0.595830:0.646652:0.595830:0.000000
 :@0.903076:0.611030:0.907291:0.611030:0.907291:0.596042:0.903076:0.596042:0.000000
:@0.524290:0.625807:0.533103:0.625807:0.533103:0.611123:0.524290:0.611123:0.000000
 Gastro-intestinal  disturbances :@0.533103:0.626323:0.802400:0.626323:0.802400:0.611335:0.533103:0.611335:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.818775:0.625807:0.827588:0.625807:0.827588:0.611123:0.818775:0.611123:0.000000
 Central :@0.827569:0.626323:0.907310:0.626323:0.907310:0.611335:0.827569:0.611335:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
nervous system effects    vertigo    dyspnoea :@0.524290:0.641616:0.907271:0.641616:0.907271:0.626628:0.524290:0.626628:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.721909:0.641100:0.730722:0.641100:0.730722:0.626416:0.721909:0.626416:0.000000
:@0.806229:0.641100:0.815042:0.641100:0.815042:0.626416:0.806229:0.626416:0.000000
 :@0.903057:0.641616:0.907271:0.641616:0.907271:0.626628:0.903057:0.626628:0.000000
:@0.524270:0.656393:0.533083:0.656393:0.533083:0.641709:0.524270:0.641709:0.000000
 Muscle cramps   Hyperuricaemia   eosinophilia :@0.533083:0.656909:0.907271:0.656909:0.907271:0.641920:0.533083:0.641920:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.657582:0.656393:0.666395:0.656393:0.666395:0.641709:0.657582:0.641709:0.000000
:@0.797089:0.656393:0.805902:0.656393:0.805902:0.641709:0.797089:0.641709:0.000000
 :@0.903057:0.656909:0.907271:0.656909:0.907271:0.641920:0.903057:0.641920:0.000000
:@0.524270:0.671686:0.533083:0.671686:0.533083:0.657002:0.524270:0.657002:0.000000
 elevated creatinine:@0.533083:0.672202:0.683097:0.672202:0.683097:0.657213:0.533083:0.657213:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Special precautions:  :@0.524270:0.691953:0.706783:0.691955:0.706783:0.675564:0.524270:0.675562:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
1:@0.696670:0.686171:0.702896:0.686171:0.702896:0.676615:0.696670:0.676615:0.000000
not recommended in moderate liver dysfunction :@0.524250:0.707248:0.907251:0.707248:0.907251:0.692259:0.524250:0.692259:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.524250:0.722025:0.533063:0.722025:0.533063:0.707340:0.524250:0.707340:0.000000
  teratogenic  in  animal  studies  and  excreted :@0.533063:0.722541:0.907212:0.722541:0.907212:0.707552:0.533063:0.707552:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
in breast milk :@0.524250:0.737834:0.651712:0.737834:0.651712:0.722845:0.524250:0.722845:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.662314:0.737318:0.671127:0.737318:0.671127:0.722633:0.662314:0.722633:0.000000
 Control heart failure first :@0.671127:0.737834:0.907251:0.737834:0.907251:0.722845:0.671127:0.722845:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903037:0.737834:0.907251:0.737834:0.907251:0.722845:0.903037:0.722845:0.000000
:@0.524250:0.752611:0.533063:0.752611:0.533063:0.737926:0.524250:0.737926:0.000000
  asymptomatic left ventricular dysfunction :@0.533063:0.753127:0.907251:0.753127:0.907251:0.738138:0.533063:0.738138:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
 :@0.903037:0.753127:0.907251:0.753127:0.907251:0.738138:0.903037:0.738138:0.000000
:@0.524250:0.767904:0.533063:0.767904:0.533063:0.753219:0.524250:0.753219:0.000000
 new York Heart association (nYHa) class II heart :@0.533063:0.768419:0.907270:0.768419:0.907270:0.753431:0.533063:0.753431:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
failure   Heart rate below 50 bpm   Concomitant :@0.524269:0.783712:0.907270:0.783712:0.907270:0.768724:0.524269:0.768724:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.575858:0.783196:0.584671:0.783196:0.584671:0.768512:0.575858:0.768512:0.000000
:@0.788583:0.783196:0.797396:0.783196:0.797396:0.768512:0.788583:0.768512:0.000000
heart-rate-reducing calcium-channel blockers not :@0.524269:0.799005:0.907270:0.799005:0.907270:0.784017:0.524269:0.784017:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
recommended   discontinue if heart rate below :@0.524269:0.814298:0.907270:0.814298:0.907270:0.799310:0.524269:0.799310:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.645169:0.813782:0.653982:0.813782:0.653982:0.799098:0.645169:0.799098:0.000000
50 bpm persists   additive efficacy in combination :@0.524269:0.829591:0.907251:0.829591:0.907251:0.814603:0.524269:0.814603:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.646304:0.829075:0.655118:0.829075:0.655118:0.814391:0.646304:0.814391:0.000000
with dihydropyridine calcium-channel blockers :@0.524269:0.844884:0.907270:0.844884:0.907270:0.829895:0.524269:0.829895:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
not established :@0.524269:0.860177:0.661352:0.860177:0.661352:0.845188:0.524269:0.845188:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.676303:0.859661:0.685116:0.859661:0.685116:0.844977:0.676303:0.844977:0.000000
  avoid with congenital :@0.685097:0.860177:0.907270:0.860177:0.907270:0.845188:0.685097:0.845188:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
Qt syndrome as Qt prolongation possibly :@0.524269:0.875470:0.907270:0.875470:0.907270:0.860481:0.524269:0.860481:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
exacerbated   Ivabradine is not recommended :@0.524269:0.890763:0.907308:0.890763:0.907308:0.875774:0.524269:0.875774:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.627582:0.890247:0.636395:0.890247:0.636395:0.875562:0.627582:0.875562:0.000000
in patients with atrial fibrillation or with other :@0.524288:0.906056:0.907308:0.906056:0.907308:0.891067:0.524288:0.891067:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
cardiac arrhythmias that interfere with sinus-node :@0.524288:0.921349:0.907270:0.921349:0.907270:0.906360:0.524288:0.906360:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
function    regular  clinical  monitoring  for  atrial :@0.524288:0.936642:0.907251:0.936642:0.907251:0.921653:0.524288:0.921653:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000
:@0.597390:0.936126:0.606203:0.936126:0.606203:0.921441:0.597390:0.921441:0.000000